Valacyclovir for Mild Cognitive Impairment

Clinical trial NCT04710030 · COMPLETED

Trial details

NCT number: NCT04710030
Sponsor: New York State Psychiatric Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment Herpes Simplex 1 Herpes Simplex 2

Start date: 2021-02-01
Primary completion: 2024-10-23
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.